2020
DOI: 10.1101/2020.09.13.295089
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

nanoDoc: RNA modification detection using Nanopore raw reads with Deep One-Class Classification

Abstract: Advances in Nanopore single-molecule direct RNA sequencing (DRS) have presented the possibility of detecting comprehensive post-transcriptional modifications (PTMs) as an alternative to experimental approaches combined with high-throughput sequencing. It has been shown that the DRS method can detect the change in the raw electric current signal of a PTM; however, the accuracy and reliability still require improvement. Here, we presented a new software, called nanoDoc, for detecting PTMs from DRS data using a d… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
18
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
5
2
1

Relationship

0
8

Authors

Journals

citations
Cited by 23 publications
(18 citation statements)
references
References 43 publications
0
18
0
Order By: Relevance
“…Comparative approaches do not require training data for known RNA modifications but instead use control or reference samples to detect meaningful shifts in signal-based features that correlate to the presence of modifications. Comparative methods such as Tombo 37 , DRUMMER 38 , nanoDOC 39 , Nanocompore 40 , ELIGOS 41 , xPore 42 , and Yanocomp 43 detect m6A sites by comparing with a sample with few or no m6A modifications. While these methods are accurate, their success relies on the availability of m6A-free control samples which typically involves silencing of specific writer genes which can be a limiting factor.…”
Section: Introductionmentioning
confidence: 99%
“…Comparative approaches do not require training data for known RNA modifications but instead use control or reference samples to detect meaningful shifts in signal-based features that correlate to the presence of modifications. Comparative methods such as Tombo 37 , DRUMMER 38 , nanoDOC 39 , Nanocompore 40 , ELIGOS 41 , xPore 42 , and Yanocomp 43 detect m6A sites by comparing with a sample with few or no m6A modifications. While these methods are accurate, their success relies on the availability of m6A-free control samples which typically involves silencing of specific writer genes which can be a limiting factor.…”
Section: Introductionmentioning
confidence: 99%
“…The first strategy, which is implemented in tools such as Epinano 14 , DiffErr 15 , Eligos 16 , and Drummer 17 , has shown interesting results despite not considering the effects of RNA modification on the raw electrical signal; however, modern basecalling models tend to become more insensitive to common PTM, with the risk that methods of this group could quickly become ineffective at detecting modifications. On the other hand, methods based on raw signal space analyses (such as Tombo 18 , Mines 19 , xPore 20 , nanom6A 21 , nanoRMS 22 , nanoDoc 23 , Yanocomp 24 , and Penguin 25 ) can lead to richer comparative analyses, but are more complicated and come with steeper computational costs. The methods described above can be further classified into two groups: de novo detection methods, that use a trained model to identify modifications, and comparative methods, where differences between two samples are evaluated to infer the presence of a modification.…”
mentioning
confidence: 99%
“…Thus, even regarding the strong effort realised by several teams the last 5 years to identify precisely Nm modification on mammalian tRNA, we do not exclude the possibility that there may still be other tRNA targets of FTSJ1 that were not uncovered yet neither by MS nor by RiboMethSeq approaches. This is why we believe that a combinatorial approach is of great interest in the future for the community as well as ongoing approaches to detect Nm modification using direct RNA sequencing nanopore approach (Ueda 2020). Importantly, our RiboMethSeq results performed on NSXLID patients’ blood-derived LCLs have with confidence extended the panel of FTSJ1’s tRNA targets, thus providing new potential biomarker sources for diagnosis of FTSJ1-related intellectual disability in the future.…”
Section: Discussionmentioning
confidence: 99%